REGENXBIO, Inc. (RGNX)
8.14
-0.27
(-3.21%)
USD |
NASDAQ |
Feb 20, 16:00
8.14
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO EPS Diluted (Quarterly) : -1.198 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -1.795 |
| Omeros Corp. | -0.4666 |
| AbbVie, Inc. | 1.024 |
| CytomX Therapeutics, Inc. | -0.0862 |
| Krystal Biotech, Inc. | 1.699 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.94M |
| Revenue (Quarterly) | 29.73M |
| Total Expenses (Quarterly) | 91.67M |
| Enterprise Value | 406.01M |
| Gross Profit Margin (Quarterly) | 67.68% |
| Profit Margin (Quarterly) | -208.3% |
| Earnings Yield | -42.87% |
| Normalized Earnings Yield | -42.87 |